Pacira Pharmaceuticals Reports Preliminary 2017 Revenues of $286.6 Million
Jan 04, 2018 12:31 pm UTC| Business
-- EXPAREL sales of $282.9 million driven by Phase 4 data, education and strategic partnerships -- PARSIPPANY, N.J., Jan. 04, 2018 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today reported preliminary unaudited...
Jan 04, 2018 12:31 pm UTC| Business
ATLANTA, Jan. 04, 2018 -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that it received validation of a...
Optium Cyber Systems Signs Second Revenue Contact
Jan 04, 2018 12:31 pm UTC| Business
THE WOODLANDS, TX., Jan. 04, 2018 -- Optium Cyber Systems, Inc. (the Company) (OTC Pink: OCSY) is pleased to announce the signing of a consulting and services agreement worth over $230,000. This is the second revenue...
Colliers International Acquires Leading Real Estate Management Services Firm in the Nordics
Jan 04, 2018 12:31 pm UTC| Business
TORONTO, Jan. 04, 2018 -- Colliers International Group Inc. (NASDAQ:CIGI) and (TSX:CIGI), a global leader in commercial real estate services, today announced the acquisition of Ovenia Group (“Ovenia” or the “Company”),...
Otonomy to Present at the J.P. Morgan Healthcare Conference
Jan 04, 2018 12:31 pm UTC| Business
SAN DIEGO, Jan. 04, 2018 -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear, today announced that David A. Weber,...
Jan 04, 2018 12:31 pm UTC| Business
Dublin, Jan. 04, 2018 -- The "Collagen and Gelatin Market for Regenerative Medicine - Global Opportunity Analysis and Industry Forecast (2017-2022)" report has been added to Research and Markets' offering. ...
MacroGenics Enters Research Collaboration with Roche to Develop a Novel Bispecific Molecule
Jan 04, 2018 12:30 pm UTC| Business
ROCKVILLE, MD, Jan. 04, 2018 -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of...
Tim Cook Cashes Out $50M in Apple Stock, Fuels Market Buzz